We are live on ! Find out more
EDRH

Edmond de Rothschild Holding Portfolio holdings

AUM $6.91B
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+19.7%
3 Year Est. Return
+58.62%
5 Year Est. Return
+75.86%
10 Year Est. Return
+284.51%
AUM
$5.59B
AUM Growth
+$624M
Cap. Flow
+$130M
Cap. Flow %
2.32%
Top 10 Hldgs %
26.02%
Holding
756
New
53
Increased
156
Reduced
230
Closed
68

Sector Composition

Rank Sector Weight
1 Healthcare 21.27%
2 Technology 21.09%
3 Communication Services 13.16%
4 Financials 9.29%
5 Consumer Discretionary 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QGEN icon
51
Qiagen
QGEN
$8.72B
$29.4M 0.53%
638,473
+26,822
+4% +$1.14M
TMO icon
52
Thermo Fisher Scientific
TMO
$220B
$29.3M 0.52%
55,247
-1,457
-3% -$705K
LQD icon
53
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
$29.1M 0.52%
262,569
-700
-0.3% -$72.9K
MET icon
54
MetLife
MET
$62.1B
$28.7M 0.51%
434,384
-1,092
-0.3% -$68.3K
PRGO icon
55
Perrigo
PRGO
$1.78B
$28.3M 0.51%
880,000
+100,000
+13% +$2.99M
SOXX icon
56
iShares Semiconductor ETF
SOXX
$45.9B
$28.2M 0.51%
147,003
+67,512
+85% +$11.3M
BKR icon
57
Baker Hughes
BKR
$61.1B
$27.5M 0.49%
804,621
-51,103
-6% -$1.74M
GTLS
58
DELISTED
Chart Industries
GTLS
$27.4M 0.49%
200,930
+55,930
+39% +$7.56M
BRK.B icon
59
Berkshire Hathaway Class B
BRK.B
$1.13T
$26.7M 0.48%
74,874
-6,438
-8% -$2.26M
KVUE icon
60
Kenvue
KVUE
$36.9B
$26.3M 0.47%
1,220,000
-10,000
-0.8% -$200K
CLVT icon
61
Clarivate
CLVT
$1.16B
$25.6M 0.46%
+2,762,000
New +$20.4M
CCC
62
CCC Intelligent Solutions
CCC
$4.08B
$23.6M 0.42%
2,070,200
-160,600
-7% -$1.87M
JPM icon
63
JPMorgan Chase
JPM
$950B
$23.4M 0.42%
137,461
+4,694
+4% +$711K
MHK icon
64
Mohawk Industries
MHK
$9.22B
$23.3M 0.42%
225,000
+5,000
+2% +$438K
BMY icon
65
Bristol-Myers Squibb
BMY
$132B
$23.2M 0.41%
451,867
+15,822
+4% +$831K
DO
66
DELISTED
Diamond Offshore Drilling, Inc.
DO
$22.9M 0.41%
1,760,000
+935,000
+113% +$12.1M
HAL icon
67
Halliburton
HAL
$26.6B
$22.8M 0.41%
630,000
-90,000
-13% -$3.46M
ILMN icon
68
Illumina
ILMN
$28.4B
$22.5M 0.4%
166,202
+37,637
+29% +$4.34M
LIN icon
69
Linde
LIN
$226B
$21.4M 0.38%
52,373
+3,088
+6% +$1.22M
BMRN icon
70
BioMarin Pharmaceuticals
BMRN
$12.4B
$21.2M 0.38%
219,533
+10
+0% +$885
PHM icon
71
Pultegroup
PHM
$25.3B
$21M 0.38%
203,725
-10,000
-5% -$850K
AIG icon
72
American International
AIG
$41.3B
$21M 0.38%
309,725
-110,381
-26% -$7.03M
ZTS icon
73
Zoetis
ZTS
$30B
$20.8M 0.37%
105,328
+9,621
+10% +$1.7M
ADBE icon
74
Adobe
ADBE
$105B
$20.8M 0.37%
34,783
+1,859
+6% +$1.07M
ELV icon
75
Elevance Health
ELV
$85.5B
$20.7M 0.37%
43,858
+788
+2% +$364K

Similar funds

Edmond de Rothschild Holding's Q4 2023 Portfolio in Review

As of Q4 2023, Edmond de Rothschild Holding held 756 positions worth $5.59B, up 13% from $4.96B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Edmond de Rothschild Holding's Q4 2023 filing shows 53 new, 156 increased, 230 reduced and 68 closed positions. Its largest new stake was Clarivate: 2,762,000 shares worth $25.6M. The largest sale was Manhattan Associates, an estimated $26.2M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.

  • Edmond de Rothschild Holding's largest Q4 2023 buy was Clarivate: 2,762,000 shares worth $25.6M.
  • Edmond de Rothschild Holding added most to Match Group in Q4 2023, an estimated $32.3M increase.
  • Edmond de Rothschild Holding's biggest Q4 2023 reduction was Manhattan Associates, cutting an estimated $26.2M.
  • Edmond de Rothschild Holding fully exited Dynavax Technologies in Q4 2023, selling an estimated $15.4M.
  • Edmond de Rothschild Holding's ten largest holdings make up 26% of its $5.59B portfolio in Q4 2023.
  • Edmond de Rothschild Holding opened 53 new positions and closed 68 in Q4 2023.
  • Edmond de Rothschild Holding's portfolio value rose 13% quarter-over-quarter to $5.59B.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2023, filed 12 Feb 2024.